DNMT1 and colorectal cancer: Research on colorectal cancer shows that 5-Aza-2′-deoxycytidine (5-AzaDC) is a DNMT inhibitor, which can significantly reduce the number and activity of colorectal CSCs and can inhibit the progression of colorectal cancer (Li et al., 2018).